SE409714B - Forfarande for framstellning av 7-(d-alfa-amino-1,4-cyklohexadien-1-ylacetamido)-desacetoxicefalosporansyra-dihydrat - Google Patents

Forfarande for framstellning av 7-(d-alfa-amino-1,4-cyklohexadien-1-ylacetamido)-desacetoxicefalosporansyra-dihydrat

Info

Publication number
SE409714B
SE409714B SE7307739A SE7307739A SE409714B SE 409714 B SE409714 B SE 409714B SE 7307739 A SE7307739 A SE 7307739A SE 7307739 A SE7307739 A SE 7307739A SE 409714 B SE409714 B SE 409714B
Authority
SE
Sweden
Prior art keywords
desacetoxic
ylacetamido
cyclohexadien
alfa
amino
Prior art date
Application number
SE7307739A
Other languages
English (en)
Inventor
F Dursch
T M Siewarga
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE409714B publication Critical patent/SE409714B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
SE7307739A 1972-06-01 1973-05-30 Forfarande for framstellning av 7-(d-alfa-amino-1,4-cyklohexadien-1-ylacetamido)-desacetoxicefalosporansyra-dihydrat SE409714B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00258767A US3819620A (en) 1972-06-01 1972-06-01 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate

Publications (1)

Publication Number Publication Date
SE409714B true SE409714B (sv) 1979-09-03

Family

ID=22982041

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7307739A SE409714B (sv) 1972-06-01 1973-05-30 Forfarande for framstellning av 7-(d-alfa-amino-1,4-cyklohexadien-1-ylacetamido)-desacetoxicefalosporansyra-dihydrat

Country Status (30)

Country Link
US (1) US3819620A (sv)
JP (1) JPS5544754B2 (sv)
KR (1) KR820001606B1 (sv)
AR (1) AR196669A1 (sv)
AT (1) AT322740B (sv)
AU (1) AU475833B2 (sv)
BE (1) BE800373A (sv)
BR (1) BR7303959D0 (sv)
CA (1) CA1004220A (sv)
CH (1) CH582185A5 (sv)
CS (1) CS178428B2 (sv)
DD (1) DD106181A5 (sv)
DE (1) DE2326880C2 (sv)
EG (1) EG11139A (sv)
ES (1) ES415420A1 (sv)
FI (1) FI57952C (sv)
FR (1) FR2186234B1 (sv)
GB (1) GB1426266A (sv)
HU (1) HU167052B (sv)
IE (1) IE38750B1 (sv)
IL (1) IL42243A (sv)
IN (1) IN138787B (sv)
IT (1) IT1068202B (sv)
NL (1) NL176267C (sv)
NO (1) NO144849C (sv)
PL (1) PL87262B1 (sv)
RO (2) RO68286A (sv)
SE (1) SE409714B (sv)
SU (1) SU465793A3 (sv)
ZA (1) ZA732889B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5725557B2 (sv) * 1972-11-17 1982-05-29
CH619233A5 (sv) * 1975-07-31 1980-09-15 Ciba Geigy Ag
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
WO1991000865A1 (en) * 1989-07-10 1991-01-24 Gema S.A. A novel stable form of cephradine, process for its production and intermediates used therein
US5278157A (en) * 1989-07-10 1994-01-11 Gema, S.A. Stable cephradine hydrate
IT1289955B1 (it) * 1997-02-21 1998-10-19 Solchem Italiana Spa Acyclovir sale sodico biidrato e sua preparazione
CN1326860C (zh) * 2002-08-06 2007-07-18 北京化工大学 头孢拉定晶体以及制备头孢拉定的方法
SI1641933T1 (en) * 2003-07-03 2018-04-30 Dsm Sinochem Pharmaceuticals Netherlands B.V. A process for the preparation of cefradine
CN104688713A (zh) * 2015-03-20 2015-06-10 江苏亚邦强生药业有限公司 一种头孢拉定胶囊剂及其制备方法
CN112206217A (zh) * 2020-10-21 2021-01-12 迪沙药业集团有限公司 一种头孢拉定药物组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485819A (en) * 1968-07-02 1969-12-23 Squibb & Sons Inc Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins

Also Published As

Publication number Publication date
IN138787B (sv) 1976-03-27
NL176267C (nl) 1985-03-18
FR2186234A1 (sv) 1974-01-11
CH582185A5 (sv) 1976-11-30
FR2186234B1 (sv) 1976-10-22
US3819620A (en) 1974-06-25
GB1426266A (en) 1976-02-25
PL87262B1 (sv) 1976-06-30
JPS4941520A (sv) 1974-04-18
DE2326880C2 (de) 1982-04-15
IT1068202B (it) 1985-03-21
DE2326880A1 (de) 1973-12-20
FI57952B (fi) 1980-07-31
AT322740B (de) 1975-06-10
DD106181A5 (sv) 1974-06-05
IL42243A0 (en) 1973-07-30
BR7303959D0 (pt) 1974-08-29
CA1004220A (en) 1977-01-25
JPS5544754B2 (sv) 1980-11-13
AU5507473A (en) 1974-11-07
SU465793A3 (ru) 1975-03-30
NL7307321A (sv) 1973-12-04
KR820001606B1 (ko) 1982-09-08
IE38750B1 (en) 1978-05-24
NO144849C (no) 1981-11-25
EG11139A (en) 1978-03-29
HU167052B (sv) 1975-07-28
ZA732889B (en) 1974-04-24
AU475833B2 (en) 1976-09-02
NO144849B (no) 1981-08-17
RO63443A (fr) 1978-07-15
FI57952C (fi) 1981-09-07
BE800373A (fr) 1973-12-03
CS178428B2 (sv) 1977-09-15
AR196669A1 (es) 1974-02-12
IL42243A (en) 1975-10-15
IE38750L (en) 1973-12-01
RO68286A (ro) 1980-12-30
ES415420A1 (es) 1976-02-16

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE7700442L (sv) Forfarande for framstellning av 6-aminopenicillansyra
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE409714B (sv) Forfarande for framstellning av 7-(d-alfa-amino-1,4-cyklohexadien-1-ylacetamido)-desacetoxicefalosporansyra-dihydrat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE414164B (sv) Forfarande for framstellning av fosforsyra
SE416473B (sv) Forfarande for framstellning av 7-(alfa-hydroxi-alfa-fenyl) acetamido-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE421424B (sv) Analogiforfarande for framstellning av lysergsyraamider
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
NO139890C (no) Fremgangsmaate ved fremstilling av n5 -methyltetrahydrohomofolinsyre
SE408643B (sv) Forfarande for framstellning av morfantridiner
SE386673B (sv) Forfarande for framstellning av 2-amino-2-oxazoliner